Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $177,690 | $220,408 | $257,967 | $182,628 |
| Dep. & Amort. | $28,015 | $24,331 | $22,871 | $21,364 |
| Deferred Tax | $0 | $0 | $0 | $13,716 |
| Stock-Based Comp. | $0 | $0 | $0 | $1,403 |
| Change in WC | $8,960 | -$34,448 | -$56,973 | -$64,034 |
| Other Non-Cash | -$76,387 | -$97,044 | $13,737 | -$5,636 |
| Operating Cash Flow | $138,278 | $113,247 | $237,602 | $149,441 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$62,219 | -$53,794 | -$51,388 | -$40,940 |
| Net Acquisitions | -$19,090 | $1,200 | $669 | $33 |
| Inv. Purchases | $0 | $0 | -$5,870 | $0 |
| Inv. Sales/Matur. | $80 | $88 | $20 | $0 |
| Other Inv. Act. | $171 | $478 | -$585 | $68 |
| Investing Cash Flow | -$81,058 | -$52,028 | -$57,154 | -$40,839 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $45,241 | -$12,920 | -$5,369 | -$4,852 |
| Stock Issued | $41,921 | $52,639 | $77,766 | $42,328 |
| Stock Repurch. | -$89,708 | -$133,900 | -$177,008 | -$78,785 |
| Dividends Paid | -$56,451 | -$69,049 | -$51,007 | -$21,132 |
| Other Fin. Act. | $3,641 | $2,388 | $1,080 | -$288 |
| Financing Cash Flow | -$55,356 | -$160,842 | -$154,537 | -$62,729 |
| Forex Effect | $0 | $0 | -$1 | $0 |
| Net Chg. in Cash | $1,864 | -$99,623 | $25,910 | $45,873 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,322 | $124,945 | $99,035 | $53,162 |
| End Cash | $27,186 | $25,322 | $124,945 | $99,035 |
| Free Cash Flow | $76,059 | $58,060 | $186,214 | $108,501 |